Skip to main content

stock

PRPH · ProPhase Labs, Inc.

What ProPhase Labs, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live PRPH price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on PRPH.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
15,592,556 as of 2026-08-17 (XBRL frame CY2026Q3I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
16.8%
Operating
-404.5%
Net
-583.9%

Returns

ROE
—
ROA
-39.1%

Health

Current ratio
0.0x
Debt/equity
—

Deep value

NCAV
-$57.72M
NCAV per share
-$3.70
Price/NCAV
Locked
NNWC
-$59.31M
NNWC per share
-$3.80
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30$1.01M$226,000-$2.65M-$3.05M
10-Q filed 2026-08-19
2026-03-31$1.17M$295,000-$2.43M-$5.17M
10-Q/A filed 2026-07-09
2025-12-31$784,000$247,000-$5.73M-$7.40M
10-K filed 2026-06-01
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30$883,000-$123,000-$4.76M-$6.84M
10-Q filed 2025-11-19
2025-06-30$1.25M$734,000-$3.89M-$4.47M
10-Q filed 2026-08-19
2025-03-31$1.43M$526,000-$3.66M$3.97M
10-Q/A filed 2026-07-09
2024-12-31$1.49M-$150,000-$17.29M-$34.36M
10-K filed 2026-06-01
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30$1.42M$215,000-$6.48M-$6.59M
10-Q filed 2025-11-19
Assets
$57.41M
Equity
-$3.11M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$4.34M-$18.05M-$14.74M—
2024-12-31$6.77M-$38.63M-$53.36M—
2023-12-31$34.98M-$21.22M-$16.78M—
2022-12-31$122.65M$23.59M$18.46M—
2021-12-31$79.04M$9.80M$6.27M—
2020-12-31$14.51M-$2.08M-$2.13M—
2019-12-31$9.88M-$3.24M-$3.15M—
2018-12-31$13.13M-$1.63M-$1.74M-$2.26M
2017-12-31$9.87M-$3.99M$40.59M-$3.05M
2016-12-31$4.21M-$2.66M-$2.87M-$1.12M

Company filings

4 offering filings in 12 months · since Mon Dec 29

events

  • Material agreement, New debt

    Material agreementNew debt
    Aug 68-K
  • Other event

    Other event
    Feb 138-K
  • Other event

    Other event
    Feb 138-K
  • Other event

    Other event
    Jan 278-K
  • Other event

    Other event
    Jan 238-K
  • Material agreement, Unregistered share sale

    Material agreementUnregistered share sale
    Jan 238-K

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named PRPH, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about PRPH.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about PRPH.

nakagai

Signals on PRPH come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the PRPH board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

ProPhase Labs, Inc. (PRPH): SEC filings, financials and insider trades · Nakagai